Investigation of cardiac status and bone mineral density in Turner syndrome

Nielsen, 1990, Sex chromosome abnormalities found among 34,910 newborn children: results from a 13-year incidence study in Arhus, Denmark, Birth Defects Orig. Artic. Ser., 26, 209 Nielsen, 1991, Chromosome abnormalities found among 34,910 newborn children: results from a 13-year incidence study in Arhus, Denmark, Hum. Genet., 87, 81, 10.1007/BF01213097 Gravholt, 1996, Prenatal and postnatal prevalence of Turner’s syndrome: a registry study, Br. Med. J., 312, 16, 10.1136/bmj.312.7022.16 Jacobs, 1974, A cytogenetic survey of 11,680 newborn infants, Ann. Hum. Genet., 37, 359, 10.1111/j.1469-1809.1974.tb01843.x Lippe, 1991, Turner syndrome, Endocrinol. Metab. Clin. North Am., 20, 121, 10.1016/S0889-8529(18)30284-6 Sybert, 2004, Turner’s syndrome, N. Engl. J. Med., 351, 1227, 10.1056/NEJMra030360 Nijhuis-van der Sanden, 2003, A review of neuropsychological and motor studies in Turner syndrome, Neurosci. Biobehav. Rev., 27, 329, 10.1016/S0149-7634(03)00062-9 Ross, 2000, Neurodevelopmental and psychosocial aspects of Turner syndrome, Ment. Retard. Dev. Disabil. Res. Rev., 6, 135, 10.1002/1098-2779(2000)6:2<135::AID-MRDD8>3.0.CO;2-K Saenger, 2001, Recommendations for the diagnosis and management of Turner syndrome, J. Clin. Endocrinol. Metab., 86, 3061, 10.1210/jc.86.7.3061 Dawson-Falk, 1992, Cardiovascular evaluation in Turner syndrome: utility of MR imaging, Australas. Radiol., 36, 204, 10.1111/j.1440-1673.1992.tb03152.x Ho, 2004, Major vascular anomalies in Turner syndrome: prevalence and magnetic resonance angiographic features, Circulation, 110, 1694, 10.1161/01.CIR.0000142290.35842.B0 Bechtold, 2004, Partial anomalous pulmonary vein connection: an underestimated cardiovascular defect in Ullrich-Turner syndrome, Eur. J. Pediatr., 163, 158, 10.1007/s00431-003-1384-7 Ostberg, 2004, A comparison of echocardiography and magnetic resonance imaging in cardiovascular screening of adults with Turner syndrome, J. Clin. Endocrinol. Metab., 89, 5966, 10.1210/jc.2004-1090 Prandstraller, 1999, Turner’s syndrome: cardiologic profile according to the different chromosomal patterns and long-term clinical follow-up of 136 nonpreselected patients, Pediatr. Cardiol., 20, 108, 10.1007/s002469900416 Sybert, 1998, Cardiovascular malformations and complications in Turner syndrome, Pediatrics, 101, e11, 10.1542/peds.101.1.e11 Price, 1986, Mortality ratios, life expectancy, and causes of death in patients with Turner’s syndrome, J. Epidemiol. Commun. Health, 40, 97, 10.1136/jech.40.2.97 Lin, 1998, Further delineation of aortic dilation, dissection, and rupture in patients with Turner syndrome, Pediatrics, 102, e12, 10.1542/peds.102.1.e12 Elsheikh, 2001, Hypertension is a major risk factor for aortic root dilatation in women with Turner’s syndrome, Clin. Endocrinol. (Oxf.), 54, 69, 10.1046/j.1365-2265.2001.01154.x Bondy, 2006, Prolongation of the QTc interval in Turner syndrome, Medicine, 85, 1, 10.1097/01.md.0000205629.16302.bc Robbins, 2003, The association between the length of the QT interval and mortality in the Cardiovascular Health Study, Am. J. Med., 115, 689, 10.1016/j.amjmed.2003.07.014 Montanez, 2004, Prolonged QTc interval and risks of total and cardiovascular mortality and sudden death in the general population: a review and qualitative overview of the prospective cohort studies, Arch. Intern. Med., 164, 943, 10.1001/archinte.164.9.943 Blair, 2004, Electrocardiographic safety profile and monitoring guidelines in pediatric psychopharmacology, J. Neural Transm., 111, 791, 10.1007/s00702-004-0153-8 Bakalov, 2003, Bone mineral density and fractures in Turner syndrome, Am. J. Med., 115, 257, 10.1016/S0002-9343(03)00364-4 Jobe, 2004, Deep venous thrombosis and Turner syndrome, J. Pediatr. Hematol. Oncol., 26, 272, 10.1097/00043426-200404000-00014 Hanton, 2003, The importance of estrogen replacement in young women with Turner syndrome, J. Womens Health (Larchmt.), 12, 971, 10.1089/154099903322643893 Gravholt, 2002, Marked disproportionality in bone size and mineral, and distinct abnormalities in bone markers and calcitropic hormones in adult Turner syndrome: a cross-sectional study, J. Clin. Endocrinol. Metab., 87, 2798, 10.1210/jc.87.6.2798 Bechtold, 2001, Musculoskeletal analyses of the forearm in young women with Turner syndrome: a study using peripheral quantitative computed tomography, J. Clin. Endocrinol. Metab., 86, 5819, 10.1210/jc.86.12.5819 Dalla Palma, 1966, Turner’s syndrome: radiological appearances, Radiol. Clin. Biol., 35, 65 Hogler, 2004, Importance of estrogen on bone health in Turner syndrome: a cross-sectional and longitudinal study using dual-energy X-ray absorptiometry, J. Clin. Endocrinol. Metab., 89, 193, 10.1210/jc.2003-030799 Rao, 1997, Pseudoautosomal deletions encompassing a novel homeobox gene cause growth failure in idiopathic short stature and Turner syndrome, Nat. Genet., 16, 54, 10.1038/ng0597-54 Ogata, 1999, SHOX: pseudoautosomal homeobox containing gene for short stature and dyschondrosteosis, Growth Horm. IGF Res., 9, 53, 10.1016/S1096-6374(99)80082-3 Ross, 2001, Phenotypes associated with SHOX deficiency, J. Clin. Endocrinol. Metab., 86, 5674, 10.1210/jc.86.12.5674 Gravholt, 2003, Increased fracture rates in Turner’s syndrome: a nationwide questionnaire survey, Clin. Endocrinol. (Oxf.), 59, 89, 10.1046/j.1365-2265.2003.01807.x Cosman, 2005, Daily and cyclic parathyroid hormone in women receiving alendronate, N. Engl. J. Med., 353, 566, 10.1056/NEJMoa050157 Sas, 2001, Bone mineral density assessed by phalangeal radiographic absorptiometry before and during long-term growth hormone treatment in girls with Turner’s syndrome participating in a randomized dose–response study, Pediatr. Res., 50, 417, 10.1203/00006450-200109000-00019 Neely, 1993, Turner syndrome adolescents receiving growth hormone are not osteopenic, J. Clin. Endocrinol. Metab., 76, 861, 10.1210/jc.76.4.861 Shaw, 1997, Bone mineral density in Turner’s syndrome – a longitudinal study, Clin. Endocrinol. (Oxf.), 47, 367, 10.1046/j.1365-2265.1997.2791084.x Carrascosa, 2000, Spontaneous, but not induced, puberty permits adequate bone mass acquisition in adolescent Turner syndrome patients, J. Bone Miner. Res., 15, 2005, 10.1359/jbmr.2000.15.10.2005 Suganuma, 2003, Bone mineral density in adult patients with Turner’s syndrome: analyses of the effectiveness of GH and ovarian steroid hormone replacement therapies, Endocr. J., 50, 263, 10.1507/endocrj.50.263 Bakalov, 2003, Selective reduction in cortical bone mineral density in Turner syndrome independent of ovarian hormone deficiency, J. Clin. Endocrinol. Metab., 88, 5717, 10.1210/jc.2003-030913 Bakalov, 2004, Growth hormone therapy and bone mineral density in Turner syndrome, J. Clin. Endocrinol. Metab., 89, 4886, 10.1210/jc.2004-0481 Odvina, 2005, Severely suppressed bone turnover: a potential complication of alendronate therapy, J. Clin. Endocrinol. Metab., 90, 1294, 10.1210/jc.2004-0952